GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
The purchase aims to build GSK’s oncology pipeline.
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion

The purchase aims to build GSK’s oncology pipeline.

The purchase aims to build GSK’s oncology pipeline.

pharma & biotech
Data Sharing in Action: When Drug Companies Open Their Trial Vaults
Data Sharing in Action: When Drug Companies Open Their Trial Vaults
Abby Olena | Dec 3, 2018
YODA, a program facilitated by Yale University researchers, has successfully distributed clinical trial records from Johnson & Johnson and Medtronic to external researchers since 2013.
First Universal Flu Vaccine to Enter Phase 3 Trial
First Universal Flu Vaccine to Enter Phase 3 Trial
Ashley P. Taylor | Nov 12, 2018
Numerous experimental vaccines that aim to provide multi-season protection are in human studies.
Illumina to Buy Pacific Biosciences for $1.2 Billion
Illumina to Buy Pacific Biosciences for $1.2 Billion
Kerry Grens | Nov 6, 2018
The purchase adds long-read sequencing to Illumina’s portfolio.
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Ashley P. Taylor | Oct 22, 2018
Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.
The UK Pharmaceutical Industry Braces for Brexit
The UK Pharmaceutical Industry Braces for Brexit
Diana Kwon | Oct 12, 2018
As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.
Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund
Catherine Offord | Oct 5, 2018
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
Startups Plan the Health Data Gold Rush
Startups Plan the Health Data Gold Rush
Shawna Williams | Oct 1, 2018
Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.
Cochrane Collaboration Expels Cofounder, Prompts Resignations
Cochrane Collaboration Expels Cofounder, Prompts Resignations
Catherine Offord | Sep 18, 2018
Physician Peter Gøtzsche, a board member of the organization, has been an outspoken critic of certain vaccines and of the pharma industry in general.
About Half of Clinical Trials Go Unreported in EU
About Half of Clinical Trials Go Unreported in EU
Sukanya Charuchandra | Sep 14, 2018
Pharma companies are more compliant in posting results compared to universities.